Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.885,11
1,58%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Panacea Acquisition Corp (NUVB) Panacea Acquisition Corp (NUVB) Notizie

Panacea Acquisition Corp

NUVB
3,25
-0,02 (-0,61%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/4/202416:01BWNuvation Bio to Present Updated Data on Taletrectinib, a..
10/4/202422:01BWNuvation Bio Completes Acquisition of AnHeart Therapeutics
28/3/202413:00BWNuvation Bio Announces Appointment of Colleen Sjogren as..
25/3/202412:00BWNuvation Bio to Acquire AnHeart Therapeutics in All-Stock..
14/3/202421:05BWNuvation Bio Doses First Patient in Phase 1/2 Study of..
04/3/202423:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/3/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202422:48EDGAR2Form 8-K - Current report
29/2/202422:01BWNuvation Bio Reports Fourth Quarter and Full Year 2023..
10/1/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/1/202422:58DJNNuvation Bio Gets New Drug Application Clearance From FDA..
08/1/202422:17EDGAR2Form 8-K - Current report
08/1/202422:10BWNuvation Bio Announces Appointment of Dr. Robert Mashal to..
08/1/202422:05BWNuvation Bio Announces FDA Clearance of Investigational New..
14/12/202322:02EDGAR2Form 8-K - Current report
27/11/202322:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/11/202322:01EDGAR2Form 8-K - Current report
13/11/202322:11EDGAR2Form 8-K - Current report
13/11/202322:05BWNuvation Bio Announces Departure of Chief Financial Officer
02/11/202321:23EDGAR2Form 8-K - Current report
02/11/202321:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:10BWNuvation Bio Reports Third Quarter 2023 Financial Results..
03/8/202323:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:17EDGAR2Form 8-K - Current report
03/8/202322:10BWNuvation Bio Reports Second Quarter 2023 Financial Results..
01/6/202322:05BWNuvation Bio Announces Formation of Oncology-Focused..
Apertura: 3,38 Min: 3,19 Max: 3,43
Chiusura: 3,27

La tua Cronologia

NYSE
NUVB
Panacea Acquisition
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network